Fungal diagnostics play a pivotal role in modern healthcare. Accurate identification of fungal infections is crucial for guiding targeted treatment strategies, preventing unnecessary antibiotic use, and reducing patient morbidity and mortality. Fungal diagnostics also aid in tracking emerging drug resistance and shaping effective infection control measures.
Catalogue No.
OLM2007
Technology
Multiplex PCR
No. of Reactions
50
Volume
Invasive Candidiasis is the most common fungal disease among hospitalised patients in the developed world, with candidaemia often cited as the fourth most common bloodstream infection within intensive care units. CandID® is a multiplex PCR test designed to detect genomic DNA of 3 commonly isolated Candida species; C. albicans, C. glabrata and C. parapsilosis.
Catalogue No.
OLM2010
Technology
PCR
No. of Reactions
50
Volume
Candida auris, a new strain of the genus Candida, is a globally emerging multidrug resistant pathogen causing nosocomial transmission. Since it was first isolated in 2009, C. auris has been associated with bloodstream and wound infections globally and has caused hospital outbreaks in several countries. C. auris is commonly resistant to the first-line antifungal drug Fluconazole, and multidrug resistant strains have been reported. AurisID® rapidly detects Candida auris within 45 minutes of nucleic acid extraction.
Catalogue No.
OLM2008
Technology
Multiplex PCR
No. of Reactions
50
Volume
Pneumocystis jirovecii is a common cause of life-threatening pneumonia in individuals with impaired immune systems. PneumID® is a multiplex PCR test designed to detect genomic DNA of Pneumocystis jirovecii from human respiratory samples within 45 minutes of DNA extraction.
PneumID® is being targeted for use as an aid in the diagnosis of respiratory infections caused by Pneumocystis jirovecii.
Catalogue No.
OLM2006
Technology
Multiplex PCR
No. of Reactions
50
Volume
AspID® is a multiplex PCR test designed to detect genomic DNA of clinically relevant Aspergillus species. AspID® rapidly detects Aspergillus species within 90 minutes of nucleic acid extraction, including specific detection of A. terreus, a fungus that is intrinsically resistant to amphotericin B.
AspID® is being targeted for use as an aid in the assessment and evaluation of patients with suspected Aspergillus infection.
Catalogue No.
OLM1906
Technology
Lateral Flow
No. of Reactions
20
Volume
A rapid immunochromatography test for the qualitative detection of Aspergillusdiagnostic antigen in human serum and bronchoalveolar lavage fluid; for use as an aid in the assessment and evaluation of patients with suspected invasive pulmonary Aspergillosis (IPA).
The AspLFD uses a monoclonal Ab that detects antigenic mannoproteins produced by the fungus during active growth and can be used to detect the Aspergillus diagnostic antigen in human serum and BAL fluids.
